世界の皮膚科処方薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Prescription Dermatological Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X17082 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、皮膚科処方薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。皮膚科処方薬の種類別市場規模（抗ニキビ治療薬、抗老化治療薬、皮膚炎治療薬、脱毛治療薬、乾癬治療薬、皮膚がん治療薬、肝斑治療薬、脂漏症治療薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・皮膚科処方薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、Merck、Bayer、Mylan Pharmaceuticals、Pfizer、F. Hoffmann-La Roche、Allergan、Bausch Health、PharmaDerm Pharmaceuticals、Allergan Inamed Corporation ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：抗ニキビ治療薬、抗老化治療薬、皮膚炎治療薬、脱毛治療薬、乾癬治療薬、皮膚がん治療薬、肝斑治療薬、脂漏症治療薬 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・皮膚科処方薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・皮膚科処方薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮膚科処方薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮膚科処方薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・皮膚科処方薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Prescription Dermatological Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Prescription Dermatological Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Prescription Dermatological Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Prescription Dermatological Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Anti-acne Drugs
Anti-aging Drugs
Dermatitis Drugs
Hair Loss Drugs
Psoriasis Drugs
Skin Cancer Drugs
Melasma Drugs
Seborrhea Drugs

Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The key market players for global Prescription Dermatological Drugs market are listed below:
Johnson & Johnson
Merck
Bayer
Mylan Pharmaceuticals
Pfizer
F. Hoffmann-La Roche
Allergan
Bausch Health
PharmaDerm Pharmaceuticals
Allergan Inamed Corporation

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Prescription Dermatological Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prescription Dermatological Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Anti-acne Drugs
1.2.3 Anti-aging Drugs
1.2.4 Dermatitis Drugs
1.2.5 Hair Loss Drugs
1.2.6 Psoriasis Drugs
1.2.7 Skin Cancer Drugs
1.2.8 Melasma Drugs
1.2.9 Seborrhea Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Prescription Dermatological Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Prescription Dermatological Drugs Market Size & Forecast
1.4.1 Global Prescription Dermatological Drugs Sales in Value (2016-2026))
1.4.2 Global Prescription Dermatological Drugs Sales in Volume (2016-2026)
1.4.3 Global Prescription Dermatological Drugs Price by Type (2016-2026) & (USD/Units)
1.5 Global Prescription Dermatological Drugs Production Capacity Analysis
1.5.1 Global Prescription Dermatological Drugs Total Production Capacity (2016-2026)
1.5.2 Global Prescription Dermatological Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prescription Dermatological Drugs Market Drivers
1.6.2 Prescription Dermatological Drugs Market Restraints
1.6.3 Prescription Dermatological Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Prescription Dermatological Drugs Product and Services
2.1.4 Johnson & Johnson Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Prescription Dermatological Drugs Product and Services
2.2.4 Merck Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Prescription Dermatological Drugs Product and Services
2.3.4 Bayer Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Mylan Pharmaceuticals
2.4.1 Mylan Pharmaceuticals Details
2.4.2 Mylan Pharmaceuticals Major Business
2.4.3 Mylan Pharmaceuticals Prescription Dermatological Drugs Product and Services
2.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Prescription Dermatological Drugs Product and Services
2.5.4 Pfizer Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business
2.6.3 F. Hoffmann-La Roche Prescription Dermatological Drugs Product and Services
2.6.4 F. Hoffmann-La Roche Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business
2.7.3 Allergan Prescription Dermatological Drugs Product and Services
2.7.4 Allergan Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Bausch Health
2.8.1 Bausch Health Details
2.8.2 Bausch Health Major Business
2.8.3 Bausch Health Prescription Dermatological Drugs Product and Services
2.8.4 Bausch Health Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 PharmaDerm Pharmaceuticals
2.9.1 PharmaDerm Pharmaceuticals Details
2.9.2 PharmaDerm Pharmaceuticals Major Business
2.9.3 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product and Services
2.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Allergan Inamed Corporation
2.10.1 Allergan Inamed Corporation Details
2.10.2 Allergan Inamed Corporation Major Business
2.10.3 Allergan Inamed Corporation Prescription Dermatological Drugs Product and Services
2.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Prescription Dermatological Drugs Sales by Manufacturer
3.1 Global Prescription Dermatological Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Prescription Dermatological Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Prescription Dermatological Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Prescription Dermatological Drugs Manufacturer Market Share
3.4.2 Top 6 Prescription Dermatological Drugs Manufacturer Market Share
3.5 Global Prescription Dermatological Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Prescription Dermatological Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prescription Dermatological Drugs Market Size by Region
4.1.1 Global Prescription Dermatological Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Prescription Dermatological Drugs Revenue by Region (2016-2026)
4.2 North America Prescription Dermatological Drugs Revenue (2016-2026)
4.3 Europe Prescription Dermatological Drugs Revenue (2016-2026)
4.4 Asia-Pacific Prescription Dermatological Drugs Revenue (2016-2026)
4.5 South America Prescription Dermatological Drugs Revenue (2016-2026)
4.6 Middle East and Africa Prescription Dermatological Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Prescription Dermatological Drugs Sales in Volume by Type (2016-2026)
5.2 Global Prescription Dermatological Drugs Revenue by Type (2016-2026)
5.3 Global Prescription Dermatological Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Prescription Dermatological Drugs Sales in Volume by Application (2016-2026)
6.2 Global Prescription Dermatological Drugs Revenue by Application (2016-2026)
6.3 Global Prescription Dermatological Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Prescription Dermatological Drugs Sales by Type (2016-2026)
7.2 North America Prescription Dermatological Drugs Sales by Application (2016-2026)
7.3 North America Prescription Dermatological Drugs Market Size by Country
7.3.1 North America Prescription Dermatological Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Prescription Dermatological Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Prescription Dermatological Drugs Sales by Type (2016-2026)
8.2 Europe Prescription Dermatological Drugs Sales by Application (2016-2026)
8.3 Europe Prescription Dermatological Drugs Market Size by Country
8.3.1 Europe Prescription Dermatological Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Prescription Dermatological Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Prescription Dermatological Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Prescription Dermatological Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Prescription Dermatological Drugs Market Size by Region
9.3.1 Asia-Pacific Prescription Dermatological Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Prescription Dermatological Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Prescription Dermatological Drugs Sales by Type (2016-2026)
10.2 South America Prescription Dermatological Drugs Sales by Application (2016-2026)
10.3 South America Prescription Dermatological Drugs Market Size by Country
10.3.1 South America Prescription Dermatological Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Prescription Dermatological Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prescription Dermatological Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Prescription Dermatological Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Prescription Dermatological Drugs Market Size by Country
11.3.1 Middle East & Africa Prescription Dermatological Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Prescription Dermatological Drugs Typical Distributors
12.3 Prescription Dermatological Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Prescription Dermatological Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Prescription Dermatological Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson Major Business
Table 5. Johnson & Johnson Prescription Dermatological Drugs Product and Services
Table 6. Johnson & Johnson Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Prescription Dermatological Drugs Product and Services
Table 10. Merck Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Prescription Dermatological Drugs Product and Services
Table 14. Bayer Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Pharmaceuticals Major Business
Table 17. Mylan Pharmaceuticals Prescription Dermatological Drugs Product and Services
Table 18. Mylan Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Prescription Dermatological Drugs Product and Services
Table 22. Pfizer Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 24. F. Hoffmann-La Roche Major Business
Table 25. F. Hoffmann-La Roche Prescription Dermatological Drugs Product and Services
Table 26. F. Hoffmann-La Roche Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Allergan Basic Information, Manufacturing Base and Competitors
Table 28. Allergan Major Business
Table 29. Allergan Prescription Dermatological Drugs Product and Services
Table 30. Allergan Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 32. Bausch Health Major Business
Table 33. Bausch Health Prescription Dermatological Drugs Product and Services
Table 34. Bausch Health Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. PharmaDerm Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. PharmaDerm Pharmaceuticals Major Business
Table 37. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Product and Services
Table 38. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Allergan Inamed Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Allergan Inamed Corporation Major Business
Table 41. Allergan Inamed Corporation Prescription Dermatological Drugs Product and Services
Table 42. Allergan Inamed Corporation Prescription Dermatological Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Prescription Dermatological Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Prescription Dermatological Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Prescription Dermatological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Prescription Dermatological Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Prescription Dermatological Drugs Production Site of Key Manufacturer
Table 48. Global Prescription Dermatological Drugs Sales by Region (2016-2021e) & (K Units)
Table 49. Global Prescription Dermatological Drugs Sales by Region (2021-2026) & (K Units)
Table 50. Global Prescription Dermatological Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Prescription Dermatological Drugs Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Prescription Dermatological Drugs Sales by Type (2016-2021e) & (K Units)
Table 53. Global Prescription Dermatological Drugs Sales by Type (2021-2026) & (K Units)
Table 54. Global Prescription Dermatological Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Prescription Dermatological Drugs Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Prescription Dermatological Drugs Price by Type (2016-2021e) & (USD/Units)
Table 57. Global Prescription Dermatological Drugs Price by Type (2021-2026) & (USD/Units)
Table 58. Global Prescription Dermatological Drugs Sales by Application (2016-2021e) & (K Units)
Table 59. Global Prescription Dermatological Drugs Sales by Application (2021-2026) & (K Units)
Table 60. Global Prescription Dermatological Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Prescription Dermatological Drugs Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Prescription Dermatological Drugs Price by Application (2016-2021e) & (USD/Units)
Table 63. Global Prescription Dermatological Drugs Price by Application (2021-2026) & (USD/Units)
Table 64. North America Prescription Dermatological Drugs Sales by Country (2016-2021e) & (K Units)
Table 65. North America Prescription Dermatological Drugs Sales by Country (2021-2026) & (K Units)
Table 66. North America Prescription Dermatological Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Prescription Dermatological Drugs Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Prescription Dermatological Drugs Sales by Type (2016-2021e) & (K Units)
Table 69. North America Prescription Dermatological Drugs Sales by Type (2021-2026) & (K Units)
Table 70. North America Prescription Dermatological Drugs Sales by Application (2016-2021e) & (K Units)
Table 71. North America Prescription Dermatological Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Europe Prescription Dermatological Drugs Sales by Country (2016-2021e) & (K Units)
Table 73. Europe Prescription Dermatological Drugs Sales by Country (2021-2026) & (K Units)
Table 74. Europe Prescription Dermatological Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Prescription Dermatological Drugs Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Prescription Dermatological Drugs Sales by Type (2016-2021e) & (K Units)
Table 77. Europe Prescription Dermatological Drugs Sales by Type (2021-2026) & (K Units)
Table 78. Europe Prescription Dermatological Drugs Sales by Application (2016-2021e) & (K Units)
Table 79. Europe Prescription Dermatological Drugs Sales by Application (2021-2026) & (K Units)
Table 80. Asia-Pacific Prescription Dermatological Drugs Sales by Region (2016-2021e) & (K Units)
Table 81. Asia-Pacific Prescription Dermatological Drugs Sales by Region (2021-2026) & (K Units)
Table 82. Asia-Pacific Prescription Dermatological Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Prescription Dermatological Drugs Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Prescription Dermatological Drugs Sales by Type (2016-2021e) & (K Units)
Table 85. Asia-Pacific Prescription Dermatological Drugs Sales by Type (2021-2026) & (K Units)
Table 86. Asia-Pacific Prescription Dermatological Drugs Sales by Application (2016-2021e) & (K Units)
Table 87. Asia-Pacific Prescription Dermatological Drugs Sales by Application (2021-2026) & (K Units)
Table 88. South America Prescription Dermatological Drugs Sales by Country (2016-2021e) & (K Units)
Table 89. South America Prescription Dermatological Drugs Sales by Country (2021-2026) & (K Units)
Table 90. South America Prescription Dermatological Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Prescription Dermatological Drugs Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Prescription Dermatological Drugs Sales by Type (2016-2021e) & (K Units)
Table 93. South America Prescription Dermatological Drugs Sales by Type (2021-2026) & (K Units)
Table 94. South America Prescription Dermatological Drugs Sales by Application (2016-2021e) & (K Units)
Table 95. South America Prescription Dermatological Drugs Sales by Application (2021-2026) & (K Units)
Table 96. Middle East & Africa Prescription Dermatological Drugs Sales by Country (2016-2021e) & (K Units)
Table 97. Middle East & Africa Prescription Dermatological Drugs Sales by Country (2021-2026) & (K Units)
Table 98. Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Prescription Dermatological Drugs Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Prescription Dermatological Drugs Sales by Type (2016-2021e) & (K Units)
Table 101. Middle East & Africa Prescription Dermatological Drugs Sales by Type (2021-2026) & (K Units)
Table 102. Middle East & Africa Prescription Dermatological Drugs Sales by Application (2016-2021e) & (K Units)
Table 103. Middle East & Africa Prescription Dermatological Drugs Sales by Application (2021-2026) & (K Units)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Prescription Dermatological Drugs Typical Distributors
Table 107. Prescription Dermatological Drugs Typical Customers
List of Figures
Figure 1. Prescription Dermatological Drugs Picture
Figure 2. Global Prescription Dermatological Drugs Sales Market Share by Type in 2020
Figure 3. Anti-acne Drugs
Figure 4. Anti-aging Drugs
Figure 5. Dermatitis Drugs
Figure 6. Hair Loss Drugs
Figure 7. Psoriasis Drugs
Figure 8. Skin Cancer Drugs
Figure 9. Melasma Drugs
Figure 10. Seborrhea Drugs
Figure 11. Global Prescription Dermatological Drugs Sales Market Share by Application in 2020
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Global Prescription Dermatological Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 16. Global Prescription Dermatological Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Prescription Dermatological Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Prescription Dermatological Drugs Sales (2016-2026) & (K Units)
Figure 37. Global Prescription Dermatological Drugs Production Capacity (2016-2026) & (K Units)
Figure 38. Global Prescription Dermatological Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Prescription Dermatological Drugs Market Drivers
Figure 40. Prescription Dermatological Drugs Market Restraints
Figure 41. Prescription Dermatological Drugs Market Trends
Figure 42. Global Prescription Dermatological Drugs Sales Market Share by Manufacturer in 2020
Figure 43. Global Prescription Dermatological Drugs Revenue Market Share by Manufacturer in 2020
Figure 44. Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Prescription Dermatological Drugs Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Prescription Dermatological Drugs Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Prescription Dermatological Drugs Sales Market Share by Region (2016-2026)
Figure 48. Global Prescription Dermatological Drugs Revenue Market Share by Region (2016-2026)
Figure 49. North America Prescription Dermatological Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Europe Prescription Dermatological Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Prescription Dermatological Drugs Revenue (2016-2026) & (USD Million)
Figure 52. South America Prescription Dermatological Drugs Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Prescription Dermatological Drugs Revenue (2016-2026) & (USD Million)
Figure 54. Global Prescription Dermatological Drugs Sales Market Share by Type (2016-2026)
Figure 55. Global Prescription Dermatological Drugs Revenue Market Share by Type (2016-2026)
Figure 56. Global Prescription Dermatological Drugs Price by Type (2016-2026) & (USD/Units)
Figure 57. Global Prescription Dermatological Drugs Sales Market Share by Application (2016-2026)
Figure 58. Global Prescription Dermatological Drugs Revenue Market Share by Application (2016-2026)
Figure 59. Global Prescription Dermatological Drugs Price by Application (2016-2026) & (USD/Units)
Figure 60. North America Prescription Dermatological Drugs Sales Market Share by Country (2016-2026)
Figure 61. North America Prescription Dermatological Drugs Revenue Market Share by Country (2016-2026)
Figure 62. North America Prescription Dermatological Drugs Sales Market Share by Type (2016-2026)
Figure 63. North America Prescription Dermatological Drugs Sales Market Share by Application (2016-2026)
Figure 64. Europe Prescription Dermatological Drugs Sales Market Share by Country (2016-2026)
Figure 65. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Europe Prescription Dermatological Drugs Sales Market Share by Type (2016-2026)
Figure 67. Europe Prescription Dermatological Drugs Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Prescription Dermatological Drugs Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Prescription Dermatological Drugs Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Prescription Dermatological Drugs Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Prescription Dermatological Drugs Sales Market Share by Application (2016-2026)
Figure 72. South America Prescription Dermatological Drugs Sales Market Share by Country (2016-2026)
Figure 73. South America Prescription Dermatological Drugs Revenue Market Share by Country (2016-2026)
Figure 74. South America Prescription Dermatological Drugs Sales Market Share by Type (2016-2026)
Figure 75. South America Prescription Dermatological Drugs Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Prescription Dermatological Drugs Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Prescription Dermatological Drugs Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

---